Last reviewed · How we verify
NCT05593926: FLORA
Fibre suppLements fOR Pre-diAbetes - An Assessment Oral Fibre Supplements on Pre-diabetes Outcome Measures
NA trial testing Myota Metabolic Regulator in Pre-diabetes in 61 participants. Completed in 15 January 2024.
26 August 2023
Quick facts
| Lead sponsor | Myota GmbH |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 61 |
| Start date | 16 November 2022 |
| Primary completion | 26 August 2023 |
| Estimated completion | 15 January 2024 |
| Sites | 2 locations across United Kingdom |
Drugs / interventions tested
- Myota Metabolic Regulator
Conditions studied
- Pre-diabetes — all drugs for Pre-diabetes →
Sponsor
Myota GmbH — full company profile →
Who can join
Adults 18 to 70, any sex, with Pre-diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This trial will investigate whether a powdered fibre mix helps maintain healthy blood glucose levels in participants with pre-diabetes, where high blood sugar is a risk of diabetes.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effects of a diverse prebiotic fibre supplement on HbA1c, insulin sensitivity and inflammatory biomarkers in pre-diabetes: a pilot placebo-controlled randomised clinical trial.
Hall CV, Twelves JL, Saxena M, Scapozza L, et al · · 2024 · cited 7× · PMID 38654680 · DOI 10.1017/s0007114524000904
Verify or expand the search:
- PubMed search for NCT05593926
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pre-diabetes
Currently open trials in the same condition.
- NCT07189234 — Long Term Impact of Time-Restricted Eating on Parameters of Cardiometabolic Health · Phase 2 · recruiting
- NCT07079722 — More Health Less Diabetes · NA · recruiting
- NCT07125365 — UK Islet Autoantibody Registry · recruiting
- NCT06862128 — OGTT at Home Using CGM vs at the Clinic · NA · recruiting
- NCT07021144 — VA|PREVENTION: Randomized Controlled Trial of a Person-Centred Digital Intervention to Prevent Diabetes in High-Risk Adu · NA · active not recruiting
Other Myota GmbH trials
Trials by the same sponsor.
- NCT07477470 — BALANCE Study: Beneficial Effects of A Diverse Prebiotic Fibre bLend on Affect, iNflammation, Cognition, and the Gut mic · NA · not yet recruiting
- NCT07201909 — CALM Study: Can A Prebiotic Fibre bLend Improve Stress, Mood, and Anxiety? · NA · recruiting
- NCT06216626 — PRebiotic Intervention for Metabolic and MEntal Health (PRIME) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05593926 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Myota GmbH
- Last refreshed: 17 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05593926.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing